Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma.
Shifeng XuYuan GuoYanwu ZengZhijian SongXiaodan ZhuNing FanZhilei ZhangGuibing RenYun-Jin ZangWei RaoPublished in: BMC cancer (2021)
The study on the clinical significance of genomic alterations directs the future development of precision medicine for intrahepatic cholangiocarcinoma treatment.